University of Southampton
Formation of nanostructured biomaterials in lab-on-a-chip microsystems
Abstract
dc:description.abstractThe development of a microfluidic-based process is presented for the production of<br/>nanomaterials in continuous-flow microreactors. A flow focusing configuration was<br/>used enabling a controllable mixing process to assist the formation of the<br/>nanomaterials through precipitation, which was triggered by a solvent exchange<br/>process. Initially, Pluronic® tri-block copolymers were used as model polymeric<br/>biomaterials, relating to drug delivery applications, to investigate the production of<br/>empty polymeric micelles (PMs). Following the production of empty PMs, the<br/>production of copolymer stabilized organic ?-carotene nanopartilces (NPs) was also<br/>investigated. The formation of both PMs and NPs, within microfluidic reactors, was<br/>further analysed by computational fluid dynamics (CFD) models in order to gain more<br/>insight into the nanoprecipitation process.<br/><br/>It has been shown that, besides the important role played by the width of the focused<br/>stream, the combined effect of reactor dimension, fluid properties, and flow condition<br/>significantly influenced the mixing condition and therefore the nucleation and growth<br/>process. When low water soluble molecules were co-precipitated together with<br/>polymeric stabilizer, competitive reactions resulted in the formation of two types of<br/>NPs, i.e., either with or without loading drug. The obtained results were interpreted by<br/>taking into consideration a new parameter representing the mismatching between the<br/>aggregations of the two precipitant species (polymer and drug), which played a<br/>decisive role in determining the size and polydispersity of the obtained NPs.<br/><br/>Finally, the established microfluidic production procedure was examined from a drug<br/>delivery point of view, by encapsulating a clinically relevant drug in PMs. PMs<br/>containing mithramycin were prepared and tested in vitro as a therapeutic protocol for<br/>beta-thalassemia.<br/><br/>In conclusion, the results of this study had demonstrated that microfluidics could<br/>facilitate the production of nanostructures for drug delivery purposes, and offer a<br/>novel method to control their properties including particle size, size distribution and<br/>pharmaceutical efficacy.
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D.
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Southampton
- Year dc:date.issued
- 2011
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Capretto, Lorenzo
- Advisor dc:contributor.advisor
-
- Zhang, X.
- ORCID person:identifier.orcid
Rights
- Language dc:language.dcterms_iso639_2
- eng